Meeting of the National Advisory Council for Healthcare Research and Quality, 8482 [2018-03926]
Download as PDF
<![CDATA[
8482
Federal Register / Vol. 83, No. 39 / Tuesday, February 27, 2018 / Notices
B. What are the equipment parameters
that are necessary to achieve desired
outcomes (e.g. flow capabilities,
settings, etc.)?
C. What are the parameters of
prescribed patient usage (e.g. frequency
of use, duration of use throughout the
day, other)?
D. In each of the above populations,
what are the parameters of patient
compliance with the prescribed usage of
the equipment?
IV. What respiratory services, other
than the technical support of the use of
the prescribed equipment, are being
provided to the above patients in the
home (e.g. patient education, ongoing
smoking cessation, respiratory therapist
led home care)?
V. What are the professional
guidelines and statements which
address KQ 1 to KQ 4?
PICOTS (Populations, Interventions,
Comparators, Outcomes, Timing,
Settings)
daltland on DSKBBV9HB2PROD with NOTICES
Interventions
I. Home mechanical ventilators (FDAapproved only) with or without
pertinent ancillary in-home services
(e.g. respiratory therapy in the
home; pharmacy reconciliation;
smoking cessation, etc.)
II. BPAP respiratory assist devices
(FDA-approved only) w/or w/o
pertinent ancillary in-home services
III. CPAP respiratory assist devices
(FDA-approved only) w/or w/o
pertinent ancillary in-home services
Comparators
I. Usual care (i.e. no mechanical
ventilation/BPAP/CPAP)
II. Different type of noninvasive
mechanical ventilation
III. Different modes of same equipment
IV. Other noninvasive ventilation
(Studies without a comparator
treatment that evaluate the effect of a
patient characteristic, laboratory
criteria, ventilator parameter, or
respiratory services on outcomes of
interest will be included)
Patient-Centered Outcomes
I. Mortality
VerDate Sep<11>2014
19:49 Feb 26, 2018
Jkt 244001
Timing
Rockville, Maryland, 20857, (301) 427–
1456. For press-related information,
please contact Alison Hunt at (301) 427–
1244 or at Alison.Hunt@ahrq.hhs.gov.
Closed captioning will be provided
during the WebEx. If another
accommodation for a disability is
needed, please contact the Food and
Drug Administration (FDA) Office of
Equal Employment Opportunity and
Diversity Management on (301) 827–
4840, no later than Friday, March 9,
2018.
I. At least 1 month of treatment
SUPPLEMENTARY INFORMATION:
Setting
I. Purpose
I. Home
II. Assisted living residence
The National Advisory Council for
Healthcare Research and Quality is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director of AHRQ on
matters related to AHRQ’s conduct of its
mission including providing guidance
on (A) priorities for health care research,
(B) the field of health care research
including training needs and
information dissemination on health
care quality and (C) the role of the
Agency in light of private sector activity
and opportunities for public private
partnerships. The Council is composed
of members of the public, appointed by
the Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
Publication Time
I. From 1995
Subgroup Analysis
Population(s)
I. Adults 18 years and older with
chronic respiratory failure due to:
A. Neuromuscular diseases
B. Thoracic restrictive diseases
(including thoracic cage
abnormalities and morbid obesity)
C. Chronic obstructive pulmonary
disease
D. Other lung diseases (cystic fibrosis,
bronchiectasis)
Outcomes
II. Hospitalization
III. Admission/readmission to intensive
care unit (ICU)
IV. Need for intubation
V. Outpatient visits
VI. Emergency room visits
VII. Disease exacerbations
VIII. Quality of life (QoL)
IX. Activities of daily living (ADL)
X. Dyspnea
XI. Sleep quality
XII. Exercise tolerance
XIII. Adverse events
I. Type of diseases
A. Neuromuscular diseases
B. Thoracic restrictive diseases
i. Thoracic cage abnormalities
ii. Morbid obesity
C. COPD
D. Other lung diseases (cystic fibrosis,
bronchiectasis)
II. Length of treatment (1 month, 3
months, 6 months and longer)
Karen J. Migdail,
Chief of Staff.
[FR Doc. 2018–03927 Filed 2–26–18; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Meeting of the National Advisory
Council for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
AGENCY:
This notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality.
SUMMARY:
The meeting will be held on
Friday, March 16, 2018, from 11:00 a.m.
to 1:00 p.m. (EST).
ADDRESSES: The meeting will be held
virtually (via WebEx).
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, Designated
Management Official, at the Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A,
DATES:
PO 00000
Frm 00065
Fmt 4703
Sfmt 9990
II. Agenda
On Friday, March 16, 2018, the
Council meeting will convene via
WebEx at 11:00 a.m. (EST), with the call
to order by the Council Chair and
approval of previous Council summary
notes. The agenda will include an
update by the AHRQ Director and an
update on the Healthcare Cost and
Utilization Project (HCUP) new release
of county level statistics on hospital
stays for alcohol, opioids, and other
drugs. The meeting is open to the
public. For information regarding how
to access the WebEx as well as other
meeting details, please go to https://
www.ahrq.gov/news/events/nac/.
Karen J. Migdail,
Chief of Staff.
[FR Doc. 2018–03926 Filed 2–26–18; 8:45 am]
BILLING CODE 4160–90–P
E:\FR\FM\27FEN1.SGM
27FEN1
]]>Agencies
[Federal Register Volume 83, Number 39 (Tuesday, February 27, 2018)]
[Notices]
[Page 8482]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03926]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Meeting of the National Advisory Council for Healthcare Research
and Quality
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces a meeting of the National Advisory
Council for Healthcare Research and Quality.
DATES: The meeting will be held on Friday, March 16, 2018, from 11:00
a.m. to 1:00 p.m. (EST).
ADDRESSES: The meeting will be held virtually (via WebEx).
FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management
Official, at the Agency for Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427-
1456. For press-related information, please contact Alison Hunt at
(301) 427-1244 or at [email protected]. Closed captioning will
be provided during the WebEx. If another accommodation for a disability
is needed, please contact the Food and Drug Administration (FDA) Office
of Equal Employment Opportunity and Diversity Management on (301) 827-
4840, no later than Friday, March 9, 2018.
SUPPLEMENTARY INFORMATION:
I. Purpose
The National Advisory Council for Healthcare Research and Quality
is authorized by Section 941 of the Public Health Service Act, 42
U.S.C. 299c. In accordance with its statutory mandate, the Council is
to advise the Secretary of the Department of Health and Human Services
and the Director of AHRQ on matters related to AHRQ's conduct of its
mission including providing guidance on (A) priorities for health care
research, (B) the field of health care research including training
needs and information dissemination on health care quality and (C) the
role of the Agency in light of private sector activity and
opportunities for public private partnerships. The Council is composed
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.
II. Agenda
On Friday, March 16, 2018, the Council meeting will convene via
WebEx at 11:00 a.m. (EST), with the call to order by the Council Chair
and approval of previous Council summary notes. The agenda will include
an update by the AHRQ Director and an update on the Healthcare Cost and
Utilization Project (HCUP) new release of county level statistics on
hospital stays for alcohol, opioids, and other drugs. The meeting is
open to the public. For information regarding how to access the WebEx
as well as other meeting details, please go to https://www.ahrq.gov/news/events/nac/.
Karen J. Migdail,
Chief of Staff.
[FR Doc. 2018-03926 Filed 2-26-18; 8:45 am]
BILLING CODE 4160-90-P
